NASDAQ
Eurofins Scientific SE (ERFSF) has a free cash flow growth of -17.77% as of Friday, May 29, 2026. This represents a 114.13% decrease compared to its 12-month average of 125.74%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.